does oscar cover glp 1 Mounjaro Maker Eli Lilly Swipes at Unapproved GLP-1 Rivals in Oscars Ad Eli Lilly's Oscars ads aim

Lilly announces $3 billion expansion to injectable drug manufacturing facility for GLP-1 injectables

The global incretin-based drugs market was valued at USD 39.4 billion in 2025 and is projected to grow from USD 41.6 billion in 2026 to USD 72.6 billion by 2035, expanding at a CAGR of 6.4% between 2026 and 2035, driven by the rising prevalence of type 2 diabetes mellitus.

The largest decline in medicines, looking at the left-shift categories in the chart in dark blue, was contraception falling 15%

Fits: 3mL vials up to 17mm in diameter

However, individuals with obesity or insulin resistance may experience enhanced clinical and cognitive outcomes

Get Started